Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for clascoterone 1% cream in acne vulgaris to assess changes in sebaceous glands and sebum. The study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clascoterone 1% cream (clascoterone)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne Vulgaris | Phase 4 | Status: ACTIVE_NOT_RECRUITING